On October 9, 2025, QYResearch, a leading thirdparty industrial research institution, officially released its professional report 2025 Global AI + Smart Ward Industry Overall Scale, Major Enterprises’ Domestic and Overseas Market Share and Ranking (Report ID: 5747917). Drawing on its largescale deployed AI + smart ward totalsolution portfolio and selfdeveloped underlying IoT and AI innovative technologies, Ocamar Information was successfully included in the report’s core enterprise directory. Listed alongside global medical giants including Siemens, Philips, Oracle, Epic Systems and Medtronic, Ocamar has become a benchmark enterprise in China’s AI + smart ward track, earning official validation of its industry standing from a globally respected data authority.

Rapid Expansion of the Global Track: Domestic and Overseas Enterprises Compete on the Same Stage
According to QYResearch report data, the AI + smart ward segment serves as a core track for healthcare digital transformation with robust growth momentum. The global market reached USD 5.8072 billion in 2024 and grew to USD 7.1808 billion in 2025. Boasting a compound annual growth rate (CAGR) of 23.7% from 2025 to 2031, the market is projected to exceed USD 25.738 billion by 2031. Monitoringoriented and nursingoriented products account for the major market share, while general hospitals represent the primary application scenario.



The global landscape now features leading international incumbents alongside rapidly rising domestic players. Top vendors profiled in the report fall into two major camps:

International TierOne Brands (Global Market Pioneers)
Siemens, Philips, Oracle, Epic Systems, Teladoc Health, Medtronic, Baxter, GE Healthcare, Stryker and other overseas players leverage mature medical device hardware and accumulated hospitalinformationsystem expertise from overseas markets. With deep roots in established European and American markets, they hold firstmover advantages in highend monitoring equipment and overseas EHR supporting systems, capturing a large share of the global market.

Core Domestic Representatives (Main Force for Local Scenario Deployment)
Local vendors such as Ocamar Information, Huawei, Winning Health, Jingyi Technology and Linkage Mobile Medical have risen rapidly by addressing clinical requirements, regulatory standards and multisystem interoperability pain points unique to Chinese hospitals. Among them, Ocamar Information is explicitly identified in the report as a benchmark enterprise in China’s AI + smartward sector. It is one of the few domestic suppliers delivering an allinone solution combining underlying IoT platform + AI algorithm engine + fullscenario hardware terminals, and is evaluated alongside global giants in this authoritative industrycompetitiveness assessment.

Breaking Through With Core Strength: Ocamar Secures TierOne Position Through Localized FullStack Solutions
Unlike overseas brands that tend to sell discrete monitoring devices and modular software systems, Ocamar has over 20 years of experience in medical IoT development and has built a differentiated, closed loop AI + smartward ecosystem — the key driver behind its QYResearch recognition.

Selfdeveloped Underlying Platform to Break Down Overseas TechnicalEcosystem Barriers Powered by its proprietary One Net Infinite® Universal Network Analysis Platform, Ocamar pioneered medical grade WiFi zero roaming architecture supporting full frequency band protocols from 400 MHz to 7125 MHz. The platform seamlessly interconnects hospital HIS, EMR, LIS, PACS and other inhospital information systems. It addresses common pain points of overseas equipment including system silos, paid interface access and poor adaptability to Chinese hospital workflows. By contrast, overseas equipment from vendors such as Siemens and Philips is mostly engineered for standardized EuropeanAmerican clinical workflows and incurs higher adaptation costs when deployed in complex multicampus Chinese hospital environments.

Native AI Ward Engine for EndtoEnd Intelligent Care Delivery Equipped with the selfdeveloped Ocamar SMAI V1.0 AI Assistant, the company delivers a comprehensive nursingfocused AI solution covering bedside voice interaction, noncontact vitalsign monitoring, AIdriven fall/pressureulcer risk prediction, intelligent infusion anomaly alerts, automated nursingtask assignment, remote ward rounds and contactfree patient services. Its noncontact intelligent monitoring mattress collects heartrate and respiratoryrate data 24/7 without wearables and enables early AIpowered warning of bedrestrelated risks. Compared with international brands that mainly focus on standalone vitalsign hardware, Ocamar achieves deep integration of hardware, AI algorithms and nursing workflows, which is wellaligned with China’s challenges of nursingstaff shortages and requirements for companionfree care policies.

LargeScale Deployment Validated by RealWorld Experience Across Thousands of Hospitals While overseas vendors mainly focus on highend singlesite tertiary hospitals, Ocamar’s AI + smartward solutions have been deployed on a large scale at more than 1,000 general and specialized hospitals nationwide, spanning orthopedics, ICU, geriatric rehabilitation and general wards. A wealth of replicable standardized reference projects have been established, covering secondarylevel hospitals all the way to toptier provincial tertiary institutions. Its volume of fullytransformed ward projects ranks among the top domestic suppliers. Constrained by long delivery cycles and limited localservice teams, overseas vendors achieve far fewer largevolume deployments within China.

High Alignment With Local Policies for CostEffective Efficiency Gains Fully aligned with national policies including the 15th FiveYear Plan for national health informatization, smarthospital initiatives and highquality companionfreecare guidelines, Ocamar provides integrated hardwareandsoftware delivery that reduces redundant infrastructure and multivendor integration costs for hospitals. Compared with high procurement and maintenance costs for imported equipment from Siemens, Philips and others, Ocamar’s domestic R&D footprint and localservice organization deliver superior costperformance and rapid aftersales response. This matches the digitaltransformation budgets of Chinese hospitals of all tiers, making Ocamar a preferred partner for newward construction and legacyward retrofits.

Endorsed by Authoritative Report: Domestic SmartHealthcare Grows Global Influence
QYResearch is a globally renowned industrialresearch institution. Its AI + smartward report draws on primary enterprise surveys, crossvalidated global revenue data and upstreamdownstream industrialchain interviews to generate objective industry insights. It serves as a key reference for hospitals, investors and industry practitioners to assess enterprise capabilities. Ocamar’s inclusion alongside global heavyweights such as Siemens and Philips marks that Chineseorigin AIsmartward solutions have obtained equaldimension recognition from a global thirdparty authority, breaking the longstanding pattern where overseas brands dominated toptier industry rankings.

According to the report, the Chinese market will become the core growth engine for global AI + smartward development from 2026 to 2031. Localized, integrated and lightweight total solutions will represent mainstream market demand. Leveraging its IoTinfrastructure strengths and clinicalAI innovation, Ocamar Information will continue iterating its full portfolio of nursingoriented, monitoringoriented and consultationoriented smartward products. It will benchmark global tierone technical standards while deepening insight into local clinical scenarios, building worldclass Chinese smartward reference solutions. Ocamar will support highquality digital upgrading for domestic hospitals and help bring Chinesedeveloped AImedical innovations to broader global markets.